Avelox 400 mg film-coated tablets
Last Updated on eMC 17-May-2017 View document | Bayer plc Contact details
Versions
- 17-May-2017 to Current
- 25-Aug-2015 to 17-May-2017
- 19-Jun-2014 to 25-Aug-2015
- 23-Nov-2012 to 19-Jun-2014
- 11-Oct-2012 to 23-Nov-2012
- 04-Jan-2012 to 11-Oct-2012
- 03-Dec-2010 to 04-Jan-2012
- 25-Oct-2010 to 03-Dec-2010
- 21-May-2009 to 25-Oct-2010
- 27-Jan-2009 to 21-May-2009
- 31-Oct-2007 to 27-Jan-2009
- 15-Nov-2006 to 31-Oct-2007
- 19-Aug-2004 to 15-Nov-2006
- 22-Dec-2003 to 19-Aug-2004
- 28-Mar-2003 to 22-Dec-2003
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 17-May-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 25-Aug-2015 and displayed until 17-May-2017
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 19-Jun-2014 and displayed until 25-Aug-2015
Reasons for adding or updating:
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 23-Nov-2012 and displayed until 19-Jun-2014
Reasons for adding or updating:
- Change to date of revision
Updated on 11-Oct-2012 and displayed until 23-Nov-2012
Reasons for adding or updating:
- Removal of Black Triangle
Updated on 04-Jan-2012 and displayed until 11-Oct-2012
Reasons for adding or updating:
- Change to date of revision
Updated on 03-Dec-2010 and displayed until 04-Jan-2012
Reasons for adding or updating:
- Changes to therapeutic indications
Updated on 25-Oct-2010 and displayed until 03-Dec-2010
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
Updated on 21-May-2009 and displayed until 25-Oct-2010
Reasons for adding or updating:
- Change to date of revision
- Change to name of manufacturer
Updated on 27-Jan-2009 and displayed until 21-May-2009
Reasons for adding or updating:
- Change to date of revision
- Change to, or new, use for medicine
- Change to warnings or special precautions for use
Updated on 31-Oct-2007 and displayed until 27-Jan-2009
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
- Change to drug interactions
Updated on 15-Nov-2006 and displayed until 31-Oct-2007
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
- Change to date of revision
Updated on 19-Aug-2004 and displayed until 15-Nov-2006
Reasons for adding or updating:
- Change of trade or generic name
- Change to appearance of the medicine
- Change to warnings or special precautions for use
- Change to date of revision
Updated on 22-Dec-2003 and displayed until 19-Aug-2004
Reasons for adding or updating:
- Update to PIL
Updated on 28-Mar-2003 and displayed until 22-Dec-2003
Reasons for adding or updating:
- New PIL for new product
Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
+44 (0)1635 563 393
+44 (0)1635 563 000
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue